No bidders have met the specification set by DB for a new generation of high-speed trains by the deadline in the tender to ...
Siemens AG is in talks about a potential deal to acquire software maker Altair Engineering Inc., people familiar with the matter said, in what would be its largest-ever acquisition. The German ...
Siemens and Microsoft have taken the Siemens Industrial Copilot to the next level, to handle demanding environments at scale Over 100 customers in Europe and the US are using the Siemens Industrial ...
Photo source: Siemens Mobility Siemens Mobility unveiled its first Velaro high-speed train for the 2,000km turnkey rail system in Egypt at InnoTrans, the world’s leading international trade fair for ...
Siemens AG is considering acquiring Altair Engineering Inc, a leading engineering software provider valued at $9.1 billion. This move aligns with Siemens' strategic shift towards software-driven ...
Gifting allows recipients to access the article for free. Siemens AG is in talks about a potential deal to acquire software maker Altair Engineering Inc., people familiar with the matter said ...
A Siemens PLM, fornecedora de serviços de gerenciamento do ciclo de vida do produto e de software de gerenciamento de operações de manufatura, anuncia a nomeação de Daniel Scuzzarello como novo ...
While the deal would not weigh heavily on Roche’s own production operations, “it could be a problem for other smaller players if there is a restriction in terms of how many CMOs are available ...
Novo Nordisk’s blockbuster Wegovy weight-loss drug beat sales expectations in the third quarter, sending shares 8.5% higher in early trade. Soaring popularity for its obesity drug has seen ...
James Manning / PA Images / Getty Images After rising in premarket trading, Novo Nordisk's U.S.-listed shares fell after the market opened Wednesday as its third-quarter sales fell short of ...
Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex ...